Claim
Strong Support
descriptive
Analysis v4

Sulforaphane is a compound found in nature that directly blocks the human SXR/hPXR receptor, which controls the production of enzymes that break down drugs and toxins.

20
Pro
0
Against

Mechanism

Synthesis from 1 study

How it works

Sulforaphane sticks to a liver receptor that normally turns on a drug-breaking enzyme. When it sticks, the receptor can't turn on the enzyme anymore. This means drugs are broken down more slowly.

Most probable mechanism

In Simple Terms

Sulforaphane attaches to a specific receptor in liver cells that normally turns on enzymes to break down drugs. When sulforaphane binds, it blocks the receptor from activating the gene that makes the CYP3A4 enzyme. Without this enzyme, the liver cannot process certain drugs as quickly.

Causal chain
1

Sulforaphane binds directly to the ligand-binding domain of the steroid and xenobiotic receptor (SXR/hPXR)

Verified by multiple studies
which leads to
2

Binding of sulforaphane prevents SXR/hPXR from recruiting coactivator proteins required for transcriptional activation

Verified by multiple studies
which leads to
3

Inhibition of SXR/hPXR transcriptional activity reduces expression of the CYP3A4 gene

Verified by multiple studies
which leads to
4

Reduced CYP3A4 enzyme levels decrease the catalytic clearance of its substrate drugs

Verified by multiple studies

Evidence from Studies

Supporting (1)

20

Community contributions welcome

Contradicting (0)

0

Community contributions welcome

No contradicting evidence found

Gold Standard Evidence Needed

According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.

Sign up to see full verdict